Colomer Bosch, RamónAlba, EmilioGonzález-Martin, AntonioPaz-Ares, LuisMartín, MiguelLlombart Bosch, AntonioRodríguez-Lescure, ÁlvaroSalvador Bofill, JavierAlbanell Mestres, JoanIsla, DoloresLomas, MaríaRodríguez, César A.Trigo, José ManuelGermà Lluch, José RamónBellmunt Molins, Joaquim, 1959-Tabernero Caturla, JosepRosell Costa, R.Aranda, EnriqueCubedo, RicardoBaselga Torres, Josep, 1959-2021Spanish Society of Medical Oncology2012-11-072012-11-072010-02-010923-7534https://hdl.handle.net/2445/32570Cancer treatment involves the participation of multiple medical specialties and, as our knowledge of the disease increases, this fact becomes even more apparent. The degree of multidisciplinarity is determined by several factors, which include the severity and type of disease, the increasing diversity in the available pharmacological and non-pharmacological therapies, and the range of specialists involved in cancer therapy, such as medical oncologists, radiotherapists, gynecologists, gastroenterologists, urologists, surgeons, and pneumologists, among others. Across Europe, the situation of cancer care can be variable due to the diversity of health systems, differences in drug reimbursement, and the degree of establishment of Medical Oncology as a medical specialty in the European Union states.4 p.application/pdfengcc-by-nc (c) Colomer et al., 2010http://creativecommons.org/licenses/by-nc/3.0/es/CàncerMedicació oralCancerOral medicationinfo:eu-repo/semantics/article5902022012-11-07info:eu-repo/semantics/openAccess20110291